1. Real-world effectiveness of ketamine in treatment-resistant depression: a systematic review & meta-analysis;Alnefeesi;J. Psychiatr. Res.,2022
2. FDA, 2021. Examples of Real-World Evidence (RWE) Used in Medical Device Regulatory Decisions. https://www.fda.gov/media/146258/download.
3. FDA, 2023a. Considerations for the Use of Real-World Data and Real-World Evidence To Support Regulatory Decision-Making for Drug and Biological Products: Guidance for Industry. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/considerations-use-real-world-data-and-real-world-evidence-support-regulatory-decision-making-drug.
4. FDA, 2023b. Real World Evidence. https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence.
5. The effects of ketamine on symptoms of depression and anxiety in real-world care settings: a retrospective controlled analysis;Hietamies;J. Affect. Disord.,2023